{
    "organizations": [],
    "uuid": "8b36057403727f5bcd9b49d07382bff579763920",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-rxi-pharmaceuticals-qtrly-loss-per/brief-rxi-pharmaceuticals-qtrly-loss-per-share-0-84-idUSASC09TOX",
    "ord_in_thread": 0,
    "title": "BRIEF-RXi Pharmaceuticals Qtrly Loss Per Share $0.84",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - RXi Pharmaceuticals Corp:\n* RXI PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS\n* RXI PHARMACEUTICALS CORP - QTRLY LOSS PER SHARE $0.84 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-27T04:52:00.000+03:00",
    "crawled": "2018-03-27T12:00:06.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "rxi",
        "pharmaceutical",
        "corp",
        "rxi",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "year",
        "end",
        "financial",
        "result",
        "recent",
        "corporate",
        "highlight",
        "rxi",
        "pharmaceutical",
        "corp",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}